BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 24, 2006
View Archived Issues
Unique IL-6 immunosuppressive activity of sanglifehrin A
Read More
Platinum-based compound with improved cell absorption designed at VCU
Read More
Serono completes phase III trial of recombinant human growth hormone in HARS
Read More
Phase IIb program planned for long-acting beta2 agonist GSK-159797
Read More
Vertex and CFFT extend cystic fibrosis research collaboration
Read More
Stem Cell Therapeutics updates progress of NTx-265
Read More
Takeda's SYR-322 begins phase III for diabetes
Read More
ATL-962 for obesity and related disease begins phase II in Japan
Read More
Phase II/III trial investigates defibrotide to prevent veno-occlusive disease
Read More
Dendreon focuses resources on Provenge
Read More
Shire to respond to NICE's review of Alzheimer's disease treatments
Read More
FDA accepts Factive filing for five-day CAP, refuses filing for ABS
Read More
Ushercell studied for treatment of bacterial vaginosis in new phase II trial
Read More
Leptin's antidepressant potential
Read More
MC160 facilitates persistent poxvirus infection but may be useful for inflammatory syndromes
Read More
Fast track designation for alfimeprase in acute peripheral arterial occlusion
Read More
Sosei withdraws Eligard submission in Japan
Read More
Japanese approval for Urief
Read More
Paxil approved for obsessive compulsive disorder in Japan
Read More
Targeting JNK to prevent AAA pathogenesis
Read More
Therapeutic agents for HIV infection reported in recent patent literature
Read More
Novel agents claimed for thrombotic disorders in recent patents
Read More
Novartis discloses novel diagnostic agents
Read More
